CNTA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.59%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $11,449,419.49

Centessa Pharmaceuticals Insider Trading History Chart

Centessa Pharmaceuticals Share Price & Price History

^$17.16

▼ -0.39 (-2.22%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

WARNING: “Buffett Indicator” flashing for first time in 50 years

From Behind the Markets | Ad

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Centessa Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/20/2024	Saurabh Saha	CEO	Sell	55,000	$17.44	$959,200.00	520,661
12/17/2024	Karen M Anderson	Insider	Sell	10,624	$17.32	$184,007.68	71,525
12/17/2024	Tia L. Bush	CTO	Sell	17,813	$18.00	$320,634.00	147,615
12/16/2024	Iqbal J Hussain	General Counsel	Sell	77,705	$16.39	$1,273,584.95	125,785
12/13/2024	Karen M Anderson	Insider	Sell	5,876	$17.01	$99,950.76	71,525
12/6/2024	Saurabh Saha	CEO	Sell	87,496	$18.46	$1,615,176.16	575,661
11/25/2024	Gregory M Weinhoff	Insider	Sell	10,000	$17.66	$176,600.00	183,266
11/25/2024	Saurabh Saha	CEO	Sell	299	$18.23	$5,450.77	575,661
11/22/2024	Saurabh Saha	CEO	Sell	1,671	$18.24	$30,479.04	575,661
11/20/2024	Saurabh Saha	CEO	Sell	55,000	$16.89	$928,950.00	575,661
10/25/2024	Gregory M Weinhoff	Insider	Sell	11,742	$15.38	$180,591.96	183,266
10/23/2024	Saurabh Saha	CEO	Sell	2,592	$15.32	$39,709.44	630,661
10/21/2024	Saurabh Saha	CEO	Sell	22,205	$15.80	$350,839.00	663,456
9/25/2024	Gregory M Weinhoff	Insider	Sell	16,619	$15.69	$260,752.11	206,750
9/20/2024	Saurabh Saha	CEO	Sell	55,000	$16.53	$909,150.00	721,924
9/10/2024	Saurabh Saha	CEO	Sell	175,000	$16.52	$2,891,000.00	776,924
9/9/2024	Gregory M Weinhoff	Insider	Sell	25,000	$15.00	$375,000.00	223,369
8/22/2024	Gregory M Weinhoff	Insider	Sell	12,198	$12.17	$148,449.66	241,171
8/22/2024	Saurabh Saha	CEO	Sell	506	$12.23	$6,188.38	823,575
8/20/2024	Saurabh Saha	CEO	Sell	4,169	$12.32	$51,362.08	827,755
3/25/2024	Karen M Anderson	Insider	Sell	51,160	$11.88	$607,780.80	71,525
2/1/2024	Harris Rotman	SVP	Sell	4,267	$8.10	$34,562.70	62,625
9/20/2023	Harris Rotman	SVP	Sell	37,484	$6.29	$235,774.36	33,500
6/1/2023	Antoine Yver	EVP	Sell	6,500	$4.45	$28,925.00	783,066
5/24/2023	Tia L. Bush	Insider	Sell	8,000	$4.48	$35,840.00	157,102
5/1/2023	Antoine Yver	EVP	Sell	6,800	$4.42	$30,056.00	789,566
1/4/2023	Antoine Yver	EVP	Sell	6,970	$3.18	$22,164.60	751,913
12/1/2022	Antoine Yver	EVP	Sell	9,400	$3.91	$36,754.00	761,151
11/1/2022	Antoine Yver	EVP	Sell	9,700	$4.03	$39,091.00	765,059
10/3/2022	Antoine Yver	EVP	Sell	12,524	$3.92	$49,094.08	774,759
10/3/2022	David M Chao	Insider	Sell	4,167	$3.95	$16,459.65	222,932
10/3/2022	Gregory M Weinhoff	CFO	Sell	4,901	$3.95	$19,358.95	231,099
10/3/2022	Iqbal J Hussain	General Counsel	Sell	4,563	$3.95	$18,023.85	154,712
10/3/2022	Thomas Templeman	CTO	Sell	2,455	$3.95	$9,697.25	135,792
9/30/2022	Antoine Yver	EVP	Sell	2,468	$4.07	$10,044.76	787,283
9/30/2022	David M Chao	Insider	Sell	3,401	$4.07	$13,842.07	227,099
9/30/2022	Gregory M Weinhoff	CFO	Sell	4,000	$4.07	$16,280.00	236,000
9/30/2022	Iqbal J Hussain	General Counsel	Sell	3,725	$4.07	$15,160.75	159,275
9/30/2022	Thomas Templeman	CTO	Sell	2,003	$4.07	$8,152.21	138,247
8/1/2022	Antoine Yver	EVP	Sell	10,423	$4.45	$46,382.35	800,174
7/18/2022	Antoine Yver	EVP	Sell	20,000	$4.87	$97,400.00	810,597
7/1/2022	Antoine Yver	EVP	Sell	9,100	$5.03	$45,773.00	730,597
6/24/2022	Saurabh Saha	CEO	Buy	10,000	$4.63	$46,300.00	38,000
6/17/2022	Antoine Yver	EVP	Sell	9,200	$4.68	$43,056.00	739,697
5/17/2022	Antoine Yver	EVP	Sell	20,222	$5.42	$109,603.24	813,675
2/2/2022	Saurabh Saha	CEO	Buy	5,000	$9.74	$48,700.00
1/28/2022	David J. Grainger	Insider	Buy	27,500	$9.05	$248,875.00

First JFK… next Elon?

From Porter & Company | Ad

I share with you in this special investigative documentary.

SEC Filings (Institutional Ownership Changes) for Centessa Pharmaceuticals (NASDAQ:CNTA)

82.01% of Centessa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Centessa Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/13/2024	Lord Abbett & CO. LLC	269,205	$4.31M	0.0%	N/A	0.204%
12/13/2024	Exome Asset Management LLC	138,152	$2.21M	1.5%	-49.7%	0.105%
11/27/2024	Franklin Resources Inc.	2,302,546	$38.36M	0.0%	+99.1%	1.746%
11/16/2024	Geode Capital Management LLC	56,597	$0.91M	0.0%	+68.7%	0.050%
11/15/2024	XTX Topco Ltd	10,174	$0.16M	0.0%	-37.9%	0.009%
11/15/2024	Jane Street Group LLC	177,260	$2.83M	0.0%	N/A	0.156%
11/15/2024	Wellington Management Group LLP	100,613	$1.61M	0.0%	N/A	0.089%
11/15/2024	State Street Corp	48,592	$0.78M	0.0%	N/A	0.043%
11/15/2024	RTW Investments LP	50,000	$0.80M	0.0%	N/A	0.044%
11/15/2024	Point72 Asset Management L.P.	2,715,663	$43.42M	0.1%	+54.1%	2.397%
11/15/2024	Janus Henderson Group PLC	1,294,864	$20.70M	0.0%	N/A	1.143%
11/15/2024	HighVista Strategies LLC	46,116	$0.74M	0.3%	N/A	0.041%
11/15/2024	Baker BROS. Advisors LP	1,227,178	$19.62M	0.2%	+123.4%	1.083%
11/14/2024	PFM Health Sciences LP	269,158	$4.30M	0.2%	-57.7%	0.238%
11/14/2024	Fred Alger Management LLC	177,553	$2.84M	0.0%	+1,515.1%	0.157%
11/14/2024	Walleye Capital LLC	11,721	$0.19M	0.0%	N/A	0.010%
11/14/2024	Suvretta Capital Management LLC	70,000	$1.12M	0.0%	N/A	0.062%
11/14/2024	Ally Bridge Group NY LLC	309,614	$4.95M	2.7%	N/A	0.273%
11/13/2024	FMR LLC	2,916,494	$46.64M	0.0%	+4.6%	2.574%
11/13/2024	The Manufacturers Life Insurance Company	264,969	$4.24M	0.0%	+88.1%	0.234%
11/5/2024	GSA Capital Partners LLP	93,658	$1.50M	0.1%	+66.1%	0.083%
11/1/2024	Atria Investments Inc	17,134	$0.27M	0.0%	+7.0%	0.015%
10/25/2024	China Universal Asset Management Co. Ltd.	13,593	$0.22M	0.0%	+99.7%	0.014%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,556	$40K	0.0%	+47.7%	0.003%
10/17/2024	Harbour Capital Advisors LLC	16,675	$0.26M	0.1%	N/A	0.017%
10/7/2024	GAMMA Investing LLC	2,972	$48K	0.0%	+103.1%	0.003%
9/16/2024	Cubist Systematic Strategies LLC	26,073	$0.24M	0.0%	-64.1%	0.026%
8/20/2024	Nantahala Capital Management LLC	450,000	$4.06M	0.2%	N/A	0.448%
8/19/2024	Point72 Asset Management L.P.	1,762,004	$15.91M	0.0%	-22.0%	1.754%
8/16/2024	Perceptive Advisors LLC	3,933,307	$35.52M	0.8%	+27.6%	3.914%
8/16/2024	Quarry LP	9,608	$87K	0.0%	+47.8%	0.010%
8/16/2024	Driehaus Capital Management LLC	2,092,011	$18.89M	0.2%	+89.5%	2.082%
8/15/2024	The Manufacturers Life Insurance Company	140,894	$1.27M	0.0%	+30.4%	0.140%
8/15/2024	Affinity Asset Advisors LLC	1,135,702	$10.26M	1.2%	+36.7%	1.130%
8/14/2024	Fred Alger Management LLC	10,993	$99K	0.0%	N/A	0.011%
8/14/2024	Sandia Investment Management LP	10,000	$90K	0.1%	N/A	0.010%
8/14/2024	Cubist Systematic Strategies LLC	26,073	$0.24M	0.0%	-64.1%	0.026%
8/14/2024	First Light Asset Management LLC	4,780,560	$43.17M	3.8%	+59.2%	4.758%
8/14/2024	Marshall Wace LLP	224,948	$2.03M	0.0%	-2.9%	0.224%
8/14/2024	Farallon Capital Management LLC	1,996,000	$18.02M	0.1%	+438.0%	1.986%
8/12/2024	XTX Topco Ltd	16,385	$0.15M	0.0%	N/A	0.016%
8/9/2024	Renaissance Technologies LLC	173,700	$1.57M	0.0%	-20.6%	0.173%
8/8/2024	American Century Companies Inc.	935,151	$8.44M	0.0%	+1.3%	0.931%
8/3/2024	TD Asset Management Inc	321,168	$2.90M	0.0%	+40.5%	0.320%
7/29/2024	HighMark Wealth Management LLC	93,000	$0.84M	0.5%	N/A	0.093%
5/30/2024	Lynx1 Capital Management LP	17,400	$0.20M	0.1%	N/A	0.017%
5/24/2024	Farallon Capital Management LLC	371,000	$4.19M	0.0%	N/A	0.369%
5/17/2024	Artal Group S.A.	1,412,500	$15.96M	0.4%	+39.5%	1.250%
5/15/2024	First Light Asset Management LLC	3,002,045	$33.92M	2.6%	N/A	2.980%
5/15/2024	Price T Rowe Associates Inc. MD	2,958,079	$33.43M	0.0%	+16.5%	2.936%
5/15/2024	Affinity Asset Advisors LLC	830,546	$9.39M	1.2%	+4.4%	0.824%
5/14/2024	EntryPoint Capital LLC	9,636	$0.11M	0.1%	N/A	0.010%
5/14/2024	Platinum Investment Management Ltd.	485,174	$5.48M	0.2%	+27.3%	0.482%
5/10/2024	Acadian Asset Management LLC	29,409	$0.33M	0.0%	N/A	0.029%
4/29/2024	China Universal Asset Management Co. Ltd.	10,817	$0.12M	0.0%	+69.2%	0.011%
2/20/2024	Quarry LP	6,000	$48K	0.0%	N/A	0.006%
2/15/2024	Octagon Capital Advisors LP	2,060,100	$16.40M	2.6%	+333.2%	2.110%
2/15/2024	BVF Inc. IL	8,774,570	$69.85M	1.8%	-3.6%	8.988%
2/14/2024	Kynam Capital Management LP	442,704	$3.52M	0.4%	-39.4%	0.453%
2/14/2024	Platinum Investment Management Ltd.	381,083	$3.03M	0.1%	+12.9%	0.390%
2/13/2024	Affinity Asset Advisors LLC	795,729	$6.33M	1.2%	-21.8%	0.815%
2/9/2024	Franklin Resources Inc.	1,115,817	$8.88M	0.0%	+34.1%	1.143%
2/9/2024	Trexquant Investment LP	14,354	$0.11M	0.0%	N/A	0.015%
2/7/2024	Jump Financial LLC	14,300	$0.11M	0.0%	N/A	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	6,394	$51K	0.0%	+371.2%	0.007%
11/15/2023	Kynam Capital Management LP	730,472	$4.73M	0.8%	+0.2%	0.768%
11/15/2023	Acuta Capital Partners LLC	323,349	$2.09M	1.4%	N/A	0.340%
11/15/2023	Adage Capital Partners GP L.L.C.	2,830,500	$18.31M	0.0%	+25.8%	2.974%
11/15/2023	Affinity Asset Advisors LLC	1,018,091	$6.59M	1.9%	+13.0%	1.045%
11/13/2023	Rathbones Group PLC	31,300	$0.20M	0.0%	N/A	0.032%
11/3/2023	Platinum Investment Management Ltd.	337,544	$2.18M	0.1%	+96.7%	0.347%
10/27/2023	TD Asset Management Inc	186,310	$1.21M	0.0%	+127.1%	0.191%
8/21/2023	Affinity Asset Advisors LLC	900,723	$5.58M	1.9%	+31.7%	0.947%
8/11/2023	Platinum Investment Management Ltd.	171,625	$1.06M	0.0%	N/A	0.180%
8/3/2023	Tanager Wealth Management LLP	696,096	$4.31M	0.9%	-5.6%	0.728%
5/16/2023	BVF Inc. IL	9,423,215	$36.28M	1.3%	+36.7%	9.961%
5/15/2023	Affinity Asset Advisors LLC	684,127	$2.63M	0.9%	+48.6%	0.723%
5/15/2023	EcoR1 Capital LLC	5,618,779	$21.63M	0.7%	+7.4%	5.939%
5/15/2023	Sio Capital Management LLC	347,869	$1.34M	0.7%	N/A	0.368%
4/18/2023	Tanager Wealth Management LLP	737,059	$2.84M	0.7%	-60.8%	0.779%
2/14/2023	EcoR1 Capital LLC	5,232,279	$16.22M	0.5%	+61.7%	5.531%
1/27/2023	Tanager Wealth Management LLP	1,878,383	$5.82M	1.6%	N/A	1.986%
11/15/2022	Kynam Capital Management LP	731,521	$2.94M	0.6%	-3.5%	0.775%
11/15/2022	EcoR1 Capital LLC	3,236,352	$13.01M	0.4%	+1,007.1%	3.431%
11/15/2022	Ensign Peak Advisors Inc	248,228	$1M	0.0%	+101.7%	0.263%
11/14/2022	Cormorant Asset Management LP	1,972,728	$7.93M	0.6%	-32.6%	2.091%
11/14/2022	Point72 Asset Management L.P.	117,800	$0.47M	0.0%	-11.8%	0.125%
8/16/2022	Woodline Partners LP	1,314,652	$6.40M	0.1%	+48.9%	1.398%
8/12/2022	Ensign Peak Advisors Inc	123,071	$0.60M	0.0%	-61.1%	0.131%
8/12/2022	Franklin Resources Inc.	832,932	$4.06M	0.0%	+35.0%	0.886%
8/11/2022	Alps Advisors Inc.	55,785	$0.27M	0.0%	N/A	0.059%
8/4/2022	TD Asset Management Inc.	82,055	$0.40M	0.0%	+146.8%	0.087%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	57,342	$0.70M	0.0%	N/A	0.061%
5/13/2022	Kynam Capital Management LP	669,100	$6M	1.9%	+179.9%	0.712%
5/4/2022	OUP Management Co. LLC	2,937,615	$26.35M	20.1%	+25.4%	3.124%
2/19/2022	Woodline Partners LP	801,136	$9.02M	0.1%	-9.3%	0.891%
2/15/2022	Samsara BioCapital LLC	1,459,693	$16.44M	3.2%	-5.1%	1.624%
2/14/2022	Virtus ETF Advisers LLC	14,798	$0.17M	0.1%	N/A	0.016%
2/14/2022	Boxer Capital LLC	1,251,137	$14.09M	0.5%	-6.2%	1.392%
2/14/2022	Point72 Asset Management L.P.	1,097,908	$12.36M	0.0%	+263.3%	1.221%

Data available starting January 2016

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipeline includes SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of narcolepsy and other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, a bi-specific monoclonal antibody for solid tumors, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; and OX2R Agonists compounds are currently in development for the treatment of narcolepsy. In addition, its products pipeline comprises ORX750, an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and earlier-stage preclinical assets and discovery-stage programs. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Today's Range

Now: $17.16

$16.94

$17.94

50 Day Range

MA: $16.64

$15.04

$18.67

52 Week Range

Now: $17.16

$6.65

$18.97

Volume

791,268 shs

Average Volume

434,271 shs

Market Capitalization

$2.26 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.52

Who are the company insiders with the largest holdings of Centessa Pharmaceuticals?: Centessa Pharmaceuticals' top insider shareholders include:
Saurabh Saha (CEO)
Antoine Yver (EVP)
Gregory M Weinhoff (Insider)
Tia L Bush (Insider)
Tia L Bush (CTO)
Iqbal J Hussain (General Counsel)
Karen M Anderson (Insider)
Harris Rotman (SVP)
Learn More about top insider investors at Centessa Pharmaceuticals.
Who are the major institutional investors of Centessa Pharmaceuticals?: Centessa Pharmaceuticals' top institutional investors include:
FMR LLC — 2.57%
Point72 Asset Management L.P. — 2.40%
Franklin Resources Inc. — 1.75%
Janus Henderson Group PLC — 1.14%
Baker BROS. Advisors LP — 1.08%
Ally Bridge Group NY LLC — 0.27%
Learn More about top institutional investors of Centessa Pharmaceuticals stock.
Which institutional investors are selling Centessa Pharmaceuticals stock?: Within the previous quarter, CNTA stock was sold by these institutional investors:
PFM Health Sciences LP
Exome Asset Management LLC
XTX Topco Ltd
During the previous year, company insiders that have sold Centessa Pharmaceuticals company stock include:
Saurabh Saha (CEO)
Antoine Yver (EVP)
Gregory M Weinhoff (Insider)
Tia L Bush (Insider)
Tia L Bush (CTO)
Iqbal J Hussain (General Counsel)
Learn More investors selling Centessa Pharmaceuticals stock.
Which institutional investors are buying Centessa Pharmaceuticals stock?: Within the previous quarter, CNTA stock was purchased by institutional investors including:
Janus Henderson Group PLC
Franklin Resources Inc.
Point72 Asset Management L.P.
Baker BROS. Advisors LP
Ally Bridge Group NY LLC
Lord Abbett & CO. LLC
Jane Street Group LLC
Fred Alger Management LLC